U
GCVRZ

UBS’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

UBS’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$48K Sell
102,382
-463
-0.5% -$225 ﹤0.01% 6903
2014
Q2 		$51K Sell
102,845
-16,392
-14% -$7.93K ﹤0.01% 6849
2014
Q1 		$37K Buy
119,237
+12,252
+11% +$4.55K ﹤0.01% 7270
2013
Q4 		$36K Sell
106,985
-12,661
-11% -$15.3K ﹤0.01% 7422
2013
Q3 		$242K Buy
119,646
+28,725
+32% +$54.7K ﹤0.01% 4948
2013
Q2 		$173K Buy
+90,921
New +$160K ﹤0.01% 5266

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

UBS's GCVRZ Position: Q3 2014 in Review

UBS reduced its Sanofi Contingent Value Rights (GCVRZ) stake by 0.45% in Q3 2014, selling an estimated $225 and leaving 102,382 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #6903.

UBS first reported a position in GCVRZ in Q2 2013 and has held it in 6 quarters since. The position peaked at $242K in Q3 2013. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2014.

  • UBS held 102,382 shares of Sanofi Contingent Value Rights worth $48K as of Q3 2014.
  • UBS sold 463 Sanofi Contingent Value Rights shares in Q3 2014, an estimated $225.
  • Sanofi Contingent Value Rights made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6903 holding.
  • UBS first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 6 quarters since.
  • UBS's Sanofi Contingent Value Rights position peaked at $242K in Q3 2013.
  • 118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.